Personalizing Colonoscopy Screening for Elderly Individuals Based on Screening History, Cancer Risk, and Comorbidity Status Could Increase Cost Effectiveness

Gastroenterology

Volumn 149, Issue 6, 2015, Pages 1425-1437

  Van Hees, Frank ^a   Saini, Sameer D ^b,c   Lansdorp Vogelaar, Iris ^a   Vijan, Sandeep ^b,c   Meester, Reinier G S ^a   De Koning, Harry J ^a   Zauber, Ann G ^d   Van Ballegooijen, Marjolein ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Center for Clinical Management Research   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Colon Cancer Screening; Individualized Care; MISCAN; Tumor

Indexed keywords

AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CLINICAL EFFECTIVENESS; COLONOSCOPY; COLORECTAL CANCER; COMORBIDITY ASSESSMENT; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RISK ASSESSMENT; SENSITIVITY ANALYSIS; VERY ELDERLY; ADENOMA; AGE; AGING; COLORECTAL NEOPLASMS; COMORBIDITY; COST BENEFIT ANALYSIS; EARLY CANCER DIAGNOSIS; ECONOMICS; ETHNOLOGY; MASS SCREENING; MIDDLE AGED; PATHOLOGY; PERSONALIZED MEDICINE; PREVALENCE; PROCEDURES; RISK FACTOR; SEX DIFFERENCE; STANDARDS; STATISTICS AND NUMERICAL DATA; TIME FACTOR; UNITED STATES; UTILIZATION;

ADENOMA; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; COLONOSCOPY; COLORECTAL NEOPLASMS; COMORBIDITY; COST-BENEFIT ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PRECISION MEDICINE; PREVALENCE; QUALITY-ADJUSTED LIFE YEARS; RISK FACTORS; SEX FACTORS; TIME FACTORS; UNITED STATES;

EID: 84945543367     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.07.042     Document Type: Article

References (51)

1. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement Ann Intern Med 149 2008 627 637
2. B. Levin, D.A. Lieberman, B. McFarland, and et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology Gastroenterology 134 2008 1570 1595
3. A. Qaseem, T.D. Denberg, R.H. Hopkins Jr., and et al. Screening for colorectal cancer: a guidance statement from the American College of Physicians Ann Intern Med 156 2012 378 386
4. D.K. Rex, D.A. Johnson, J.C. Anderson, and et al. American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected] Am J Gastroenterol 104 2009 739 750
5. C.J. Kahi, M. van Ryn, B. Juliar, and et al. Provider recommendations for colorectal cancer screening in elderly veterans J Gen Intern Med 24 2009 1263 1268
6. S.D. Saini, S. Vijan, P. Schoenfeld, and et al. Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study BMJ 348 2014 g1247
7. J.S. Goodwin, A. Singh, N. Reddy, and et al. Overuse of screening colonoscopy in the Medicare population Arch Intern Med 171 2011 1335 1343
8. K.M. Sheffield, Y. Han, Y.F. Kuo, and et al. Potentially inappropriate screening colonoscopy in Medicare patients: variation by physician and geographic region JAMA Intern Med 173 2013 542 550
9. L.C. Walter, K. Lindquist, S. Nugent, and et al. Impact of age and comorbidity on colorectal cancer screening among older veterans Ann Intern Med 150 2009 465 473
10. J.A. Shapiro, C.N. Klabunde, T.D. Thompson, and et al. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey Cancer Epidemiol Biomarkers Prev 21 2012 895 904
11. T.C. Arminski, and D.W. McLean Incidence and distribution of adenomatous polyps of the colon and rectum based on 1,000 autopsy examinations Dis Colon Rectum 7 1964 249 261
12. J.A. Bombi Polyps of the colon in Barcelona, Spain. An autopsy study Cancer 61 1988 1472 1476
13. I. Chapman Adenomatous polypi of large intestine: incidence and distribution Ann Surg 157 1963 223 226
14. J.C. Clark, Y. Collan, T.J. Eide, and et al. Prevalence of polyps in an autopsy series from areas with varying incidence of large-bowel cancer Int J Cancer 36 1985 179 186
15. J.R. Jass, P.J. Young, and E.M. Robinson Predictors of presence, multiplicity, size and dysplasia of colorectal adenomas. A necropsy study in New Zealand Gut 33 1992 1508 1514
16. L.G. Johannsen, O. Momsen, and N.O. Jacobsen Polyps of the large intestine in Aarhus, Denmark. An autopsy study Scand J Gastroenterol 24 1989 799 806
17. R.R. Rickert, O. Auerbach, L. Garfinkel, and et al. Adenomatous lesions of the large bowel: an autopsy survey Cancer 43 1979 1847 1857
18. M.H. Vatn, and H. Stalsberg The prevalence of polyps of the large intestine in Oslo: an autopsy study Cancer 49 1982 819 825
19. A.R. Williams, B.A. Balasooriya, and D.W. Day Polyps and cancer of the large bowel: a necropsy study in Liverpool Gut 23 1982 835 842
20. L.J. Blatt Polyps of the colon and rectum: incidence and distribution Dis Colon Rectum 4 1961 277 282
21. Surveillance, Epidemiology, and End Results (SEER) Program SEER∗Stat Database: Incidence-SEER 9 Regs Limited-Use, Nov 2002 Sub (1973-2000) National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2003, based on the November 2002 submission, 2003 2003 National Cancer Institute Bethesda, MD
22. C.M. Rutter, E.A. Johnson, E.J. Feuer, and et al. Secular trends in colon and rectal cancer relative survival J Natl Cancer Inst 105 2013 1806 1813
23. W.S. Atkin, R. Edwards, I. Kralj-Hans, and et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial Lancet 375 2010 1624 1633
24. J.D. Hardcastle, J.O. Chamberlain, M.H. Robinson, and et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer Lancet 348 1996 1472 1477
25. O.D. Jorgensen, O. Kronborg, and C. Fenger A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds Gut 50 2002 29 32
26. I. Lansdorp-Vogelaar, M. van Ballegooijen, R. Boer, and et al. A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials Cancer 115 2009 2410 2419
27. J.S. Mandel, T.R. Church, F. Ederer, and et al. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood J Natl Cancer Inst 91 1999 434 437
28. A.N. Freedman, M.L. Slattery, R. Ballard-Barbash, and et al. Colorectal cancer risk prediction tool for white men and women without known susceptibility J Clin Oncol 27 2009 686 693
29. Y. Park, A.N. Freedman, M.H. Gail, and et al. Validation of a colorectal cancer risk prediction model among white patients age 50 years and older J Clin Oncol 27 2009 694 698
30. H. Cho, C.N. Klabunde, K.R. Yabroff, and et al. Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies Ann Intern Med 159 2013 667 676
31. D.A. Lieberman, D.K. Rex, S.J. Winawer, and et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer Gastroenterology 143 2012 844 857
32. J.C. van Rijn, J.B. Reitsma, J. Stoker, and et al. Polyp miss rate determined by tandem colonoscopy: a systematic review Am J Gastroenterol 101 2006 343 350
33. F. van Hees, A.G. Zauber, C.N. Klabunde, and et al. The appropriateness of more intensive colonoscopy screening than recommended in Medicare beneficiaries: a modeling study JAMA Intern Med 174 2014 1568 1576
34. J.L. Warren, C.N. Klabunde, A.B. Mariotto, and et al. Adverse events after outpatient colonoscopy in the Medicare population Ann Intern Med 150 2009 849 857
35. N.M. Gatto, H. Frucht, V. Sundararajan, and et al. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study J Natl Cancer Inst 95 2003 230 236
36. R.M. Ness, A.M. Holmes, R. Klein, and et al. Utility valuations for outcome states of colorectal cancer Am J Gastroenterol 94 1999 1650 1657
37. A.G. Zauber, I. Lansdorp-Vogelaar, J. Wilschut, and et al. Cost-effectiveness of DNA stool testing to screen for colorectal cancer 2007 Agency for Healthcare Research and Quality Rockville, MD http://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id52TA.pdf Accessed May 10, 2015
38. D.A. Leffler, R. Kheraj, S. Garud, and et al. The incidence and cost of unexpected hospital use after scheduled outpatient endoscopy Arch Intern Med 170 2010 1752 1757
39. Bureau of Labor Statistics, US Department of Labor. Occupational employment statistics: May 2012 national occupational employment and wage estimates-United States. http://www.bls.gov/oes/2012/may/oes-nat.htm. Accessed May 10, 2015.
40. K.R. Yabroff, E.B. Lamont, A. Mariotto, and et al. Cost of care for elderly cancer patients in the United States J Natl Cancer Inst 100 2008 630 641
41. Bureau of Labor Statistics, US Department of Labor. CPI detailed report: data for January 2013. http://www.bls.gov/cpi/cpid1301.pdf. Accessed May 10, 2015.
42. J.E. Siegel, G.W. Torrance, L.B. Russell, and et al. Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine Pharmacoeconomics 11 1997 159 168
43. P.J. Neumann, J.T. Cohen, and M.C. Weinstein Updating cost-effectiveness - the curious resilience of the $50,000-per-QALY threshold N Engl J Med 371 2014 796 797
44. F. van Hees, J.D. Habbema, R.G. Meester, and et al. Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis Ann Intern Med 160 2014 750 759
45. I. Lansdorp-Vogelaar, R. Gulati, A.B. Mariotto, and et al. Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits Ann Intern Med 161 2014 104 112
46. L.C. Walter, and K.E. Covinsky Cancer screening in elderly patients: a framework for individualized decision making JAMA 285 2001 2750 2756
47. I. Lansdorp-Vogelaar, M. van Ballegooijen, A.G. Zauber, and et al. Individualizing colonoscopy screening by sex and race Gastrointest Endosc 70 2009 96 108
48. L.F. McMahon Jr., R. Hayward, S. Saint, and et al. Univariate solutions in a multivariate world: can we afford to practice as in the "good old days"? Am J Manag Care 11 2005 473 476
49. J.A. Wilschut, E.W. Steyerberg, M.E. van Leerdam, and et al. How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer? Cancer 117 2011 4166 4174
50. D.A. Lieberman, J.L. Williams, J.L. Holub, and et al. Colonoscopy utilization and outcomes 2000 to 2011 Gastrointest Endosc 80 2014 133 143
51. A.M. Torke, P.H. Schwartz, L.R. Holtz, and et al. Older adults and forgoing cancer screening: "I think it would be strange." JAMA Intern Med 173 2013 526 531